Rgene Corporation
Clinical trials sponsored by Rgene Corporation, explained in plain language.
-
Mushroom extract boosts chemo in lung cancer fight?
Disease control Not yet recruitingThis early-stage study tests a mushroom-derived liquid (BLEX 404) combined with standard chemotherapy in 32 adults with advanced non-small cell lung cancer that has no EGFR mutation. The goal is to see if the combination is safe and helps shrink tumors by boosting the immune syst…
Phase: PHASE1, PHASE2 • Sponsor: Rgene Corporation • Aim: Disease control
Last updated May 03, 2026 08:52 UTC
-
New combo therapy targets hard-to-treat pancreatic cancer
Disease control Not yet recruitingThis study tests a new oral drug called BLEX 404 combined with standard chemotherapy (gemcitabine) in 40 adults with advanced pancreatic cancer that cannot be removed by surgery or has spread. The goal is to find a safe dose and see if the combination shrinks tumors. Participants…
Phase: PHASE2 • Sponsor: Rgene Corporation • Aim: Disease control
Last updated Apr 26, 2026 19:38 UTC